Literature DB >> 17495577

Behavioral therapies trials: a case example.

Marianne T Marcus1, Patricia R Liehr, Joy Schmitz, F Gerald Moeller, Paul Swank, Micki Fine, Stanley Cron, L Kian Granmayeh, Deidra D Carroll.   

Abstract

BACKGROUND: Behavior change is integral to the prevention and treatment of many disorders associated with deleterious lifestyles. Rigorous scientific testing of behavior change interventions is an important goal for nursing research. APPROACH: The stage model for behavioral therapy development is recommended as a useful framework for evaluating behavior change strategies. The NIH model specifies three stages from initial testing of novel behavioral therapies to their dissemination in community settings. Definitions of each step in a Stage I trial and a case example of Mindfulness-Based Stress Reduction (MBSR) in therapeutic community treatment are provided.
RESULTS: It is feasible to adapt a behavioral therapy such as MBSR using the stage model framework. Steps in the process include: (a) determining pilot study design and describing the population; (b) modifying the intervention and developing the manual; (c) training the teachers; (d) implementing a pilot study; and (e) monitoring treatment integrity. DISCUSSION: The development of behavior therapies requires the same scientific rigor used in pharmacotherapy research. Stage I of the model enables consideration of the "dose" of a behavioral intervention necessary to achieve behavior change in a defined population. The stage model offers an excellent approach to achieving rigor in a variety of potentially useful therapies of interest to nurse researchers.

Mesh:

Year:  2007        PMID: 17495577      PMCID: PMC2398691          DOI: 10.1097/01.NNR.0000270024.52242.39

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  15 in total

1.  A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions.

Authors:  K M Carroll; C Nich; R L Sifry; K F Nuro; T L Frankforter; S A Ball; L Fenton; B J Rounsaville
Journal:  Drug Alcohol Depend       Date:  2000-01-01       Impact factor: 4.492

2.  Measuring client clinical progress in therapeutic community treatment. The therapeutic community Client Assessment Inventory, Client Assessment Summary, and Staff Assessment Summary.

Authors:  D Kressel; G De Leon; M Palij; G Rubin
Journal:  J Subst Abuse Treat       Date:  2000-10

3.  The role of therapist characteristics in training effects in cognitive, supportive-expressive, and drug counseling therapies for cocaine dependence.

Authors:  L Siqueland; P Crits-Christoph; J P Barber; S F Butler; M Thase; L Najavits; L S Onken
Journal:  J Psychother Pract Res       Date:  2000

4.  The relationship between length of stay in drug-free therapeutic communities and neurocognitive functioning.

Authors:  W Fals-Stewart; J Schafer
Journal:  J Clin Psychol       Date:  1992-07

5.  Therapeutic communities. Enhancing retention in treatment using "Senior Professor" staff.

Authors:  G De Leon; J Hawke; N Jainchill; G Melnick
Journal:  J Subst Abuse Treat       Date:  2000-12

6.  Treatment fidelity in behavior change research: a case example.

Authors:  Barbara Resnick; Pia Inguito; Denise Orwig; Janet Yu Yahiro; William Hawkes; Michele Werner; Sheryl Zimmerman; Jay Magaziner
Journal:  Nurs Res       Date:  2005 Mar-Apr       Impact factor: 2.381

7.  Treatment level progress and time spent in treatment in the prediction of outcomes following drug-free therapeutic community treatment.

Authors:  J W Toumbourou; M Hamilton; B Fallon
Journal:  Addiction       Date:  1998-07       Impact factor: 6.526

8.  Training therapists to perform interpersonal psychotherapy in clinical trials.

Authors:  B J Rounsaville; E S Chevron; M M Weissman; B A Prusoff; E Frank
Journal:  Compr Psychiatry       Date:  1986 Jul-Aug       Impact factor: 3.735

9.  A national evaluation of treatment outcomes for cocaine dependence.

Authors:  D D Simpson; G W Joe; B W Fletcher; R L Hubbard; M D Anglin
Journal:  Arch Gen Psychiatry       Date:  1999-06

Review 10.  Behavioral therapies for drug abuse.

Authors:  Kathleen M Carroll; Lisa S Onken
Journal:  Am J Psychiatry       Date:  2005-08       Impact factor: 18.112

View more
  6 in total

1.  Linguistic analysis to assess the effect of a mindfulness intervention on self-change for adults in substance use recovery.

Authors:  Patricia Liehr; Marianne T Marcus; Deidra Carroll; L Kian Granmayeh; Stanley G Cron; James W Pennebaker
Journal:  Subst Abus       Date:  2010-04       Impact factor: 3.716

Review 2.  Mindfulness meditation for substance use disorders: a systematic review.

Authors:  Aleksandra Zgierska; David Rabago; Neharika Chawla; Kenneth Kushner; Robert Koehler; Alan Marlatt
Journal:  Subst Abus       Date:  2009 Oct-Dec       Impact factor: 3.716

3.  Evaluating Mindfulness-Based Stress Reduction: analyzing stories of stress to formulate focus group questions.

Authors:  Deidra Carroll; Bernadette Lange; Patricia Liehr; Sommer Raines; Marianne T Marcus
Journal:  Arch Psychiatr Nurs       Date:  2008-04       Impact factor: 2.218

4.  Mindfulness Meditation-Based Intervention Is Feasible, Acceptable, and Safe for Chronic Low Back Pain Requiring Long-Term Daily Opioid Therapy.

Authors:  Aleksandra E Zgierska; Cindy A Burzinski; Jennifer Cox; John Kloke; Janice Singles; Shilagh Mirgain; Aaron Stegner; Dane B Cook; Miroslav Bačkonja
Journal:  J Altern Complement Med       Date:  2016-06-07       Impact factor: 2.579

5.  Efficacy of mindfulness-based addiction treatment (MBAT) for smoking cessation and lapse recovery: A randomized clinical trial.

Authors:  Jennifer Irvin Vidrine; Claire Adams Spears; Whitney L Heppner; Lorraine R Reitzel; Marianne T Marcus; Paul M Cinciripini; Andrew J Waters; Yisheng Li; Nga Thi To Nguyen; Yumei Cao; Hilary A Tindle; Micki Fine; Linda V Safranek; David W Wetter
Journal:  J Consult Clin Psychol       Date:  2016-09

6.  Mindfulness and its efficacy for psychological and biological responses in women with breast cancer.

Authors:  Elisabeth Kenne Sarenmalm; Lena B Mårtensson; Bengt A Andersson; Per Karlsson; Ingrid Bergh
Journal:  Cancer Med       Date:  2017-04-18       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.